Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Reduced antigenicity – reduced ability to bind complement – or...
Patent
1977-04-22
1978-07-11
Phillips, Delbert R.
Drug, bio-affecting and body treating compositions
Immunoglobulin, antiserum, antibody, or antibody fragment,...
Reduced antigenicity, reduced ability to bind complement, or...
2601125LH, A61K 3700, C07C10352
Patent
active
041002741
ABSTRACT:
The disclosure relates to novel luliberin analogues which possess luliberin agonist activity, to processes for their manufacture and to compositions containing them. Typical of the peptides disclosed is ##STR1## in which A is D-Phe, D-Tyr(Me) or D-Ser(Bu.sup.t).
REFERENCES:
patent: 3896104 (1975-07-01), McKinley et al.
patent: 3901872 (1976-08-01), McKinley et al.
patent: 3914412 (1975-10-01), Cendrich et al.
patent: 3971737 (1976-07-01), Garsky
patent: 3992530 (1976-11-01), Foell et al.
patent: 4005063 (1977-01-01), Gendrich et al.
patent: 4010125 (1977-03-01), Schally et al.
patent: 4010149 (1977-03-01), Baka et al.
patent: 4018726 (1977-04-01), Schally et al.
patent: 4024121 (1977-05-01), Schally et al.
patent: 4024248 (1977-05-01), Konig et al.
Dutta Anand Swaroop
Furr Barrington John Albert
Giles Michael Brian
Imperial Chemical Industries Limited
Phillips Delbert R.
LandOfFree
Polypeptide does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Polypeptide, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Polypeptide will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-262653